Skip to content

Clinical trials

Terminated Parkinsonian Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinsonian Disorders Status: Terminated Country / region: United States Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20082
20121
20142
20172
20181
20191
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Adamas Pharmaceuticals, Inc.2
GE Healthcare1
Johns Hopkins University1
National Heart, Lung, and Blood Institute (NHLBI)1
Neurologix, Inc.1
Northwestern University1
Scion NeuroStim1
The Cooper Health System1
Theravance Biopharma1
Titan Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease11
Parkinsonian Disorders11
Dyskinesias3
Movement Disorders3
Brain Diseases2
Central Nervous System Diseases2
Neurodegenerative Diseases2
Basal Ganglia Diseases1
Dizziness1
Fatigue1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.